Number of the records: 1

Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin

SYSNO	0522432
Title	Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin
Author(s)	Trousil, Jiří (UMCH-V) [SUPRAMOL]_{RID, ORCID} Pavliš, O. (CZ) Kubíčková, P. (CZ) Škorič, M. (CZ) Marešová, V. (CZ) Pavlova, Ewa (UMCH-V) [MATER]_RID Knudsen, K. D. (NO) Dai, Y.-S. (TW) Zimmerman, M. (US) Dartois, V. (US) Fang, J.-Y. (TW) Hrubý, Martin (UMCH-V) [SUPRAMOL]_{RID, ORCID}
Corespondence/senior	Trousil, Jiří - Korespondující autor Hrubý, Martin - Korespondující autor
Source Title	Journal of Controlled Release. Roč. 321, 10 May (2020), s. 312-323. - : Elsevier
Document Type	Článek v odborném periodiku
Grant	GA17-07164S GA ČR - Czech Science Foundation (CSF), CZ - Czech Republic
	GA17-09998S GA ČR - Czech Science Foundation (CSF), CZ - Czech Republic
	LO1507 GA MŠMT - Ministry of Education, Youth and Sports (MEYS), CZ - Czech Republic
	TWN-18-10, CZ - Czech Republic
	VAJVA-19-55, CZ - Czech Republic
Institutional support	UMCH-V - RVO:61389013
Language	eng
Country	NL
Keywords	tuberculosis * nanoparticles * drug delivery system
URL	https://www.sciencedirect.com/science/article/pii/S0168365920301164?via%3Dihub
Permanent Link	http://hdl.handle.net/11104/0307136

Number of the records: 1